Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?
Department of Pediatrics, University of California at Davis, CA 95817, USA. nsglaser@ucdavis.edu
Nicole S
NS
Glaser
David H
DH
Geller
Andrea
A
Haqq
Stephen
S
Gitelman
Mary
M
Malloy
D000328:Adult; D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000209:etiology; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000453:epidemiology / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*; D007333:Insulin Resistance; D050356:Lipid Metabolism; D017410:Practice Guidelines as Topic; D012306:Risk
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors